|
|---|
|
Lu P,
Wang S,
Franzen CA,
Venkataraman G,
McClure R,
Li L,
Wu W,
Niu N,
Sukhanova M,
Pei J,
Baldwin DA,
Nejati R,
Wasik MA,
Khan N,
Tu Y,
Gao J,
Chen Y,
Ma S,
Larson RA,
Wang YL. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.
Blood Cancer J. 2021 Feb 18;11(2)
:39. PMC ID:PMC7893066. |
|
Winn JS,
Hasse Z,
Slifker M,
Pei J,
Arisi-Fernandez SM,
Talarchek JN,
Obeid E,
Baldwin DA,
Gong Y,
Ross E,
Cristofanilli M,
Alpaugh RK,
Fernandez SV. Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer.
Int J Mol Sci. 2020 Feb 14;21(4)
. PMC ID:PMC7072950. |
|
Baldwin DA,
Sarnowski CP,
Reddy SA,
Blair IA,
Clapper M,
Lazarus P,
Li M,
Muscat JE,
Penning TM,
Vachani A,
Whitehead AS. Development of a genotyping microarray for studying the role of gene-environment interactions in risk for lung cancer.
J Biomol Tech. 2013 Dec;24(4)
:198-217. PMC ID:PMC3792704. |
|
Faculty
Publications
